| 20478 |
THE ONCOLOGIST |
Thalidomide in advanced hepatocellular carcinoma with optional low-dose interferon-alpha2a upon progression. |
2005-10-01 |
10.1634/theoncologist.10-9-718 |
Schwartz J. D. |
| 20477 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Circadian rhythm of maternal blood pressure and fetal growth |
2005-10-01 |
10.1016/s0753-3322(05)80015-0 |
Maggioni C., Cornélissen G., Otsuka K., Halberg F., Consonni D., Nicolini U. |
| 20476 |
THE ONCOLOGIST |
Weekly administration of docetaxel and paclitaxel in metastatic or advanced breast cancer. |
2005-10-01 |
10.1634/theoncologist.10-9-665 |
Eniu A. |
| 20475 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Plasma catecholamines: follow-up on 10-year study in health and cardiovascular disease |
2005-10-01 |
10.1016/s0753-3322(05)80029-0 |
Prikryl P., Cornélissen G., Otsuka K., Halberg F. |
| 20474 |
THE ONCOLOGIST |
Topotecan as second-line therapy for ovarian cancer: dosage versus toxicity. |
2005-10-01 |
10.1634/theoncologist.10-9-695 |
Markman M. |
| 20473 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Chronomics affirm extending scope of lead in phase of duodenal vs. pineal circadian melatonin rhythms |
2005-10-01 |
10.1016/s0753-3322(05)80035-6 |
Poeggeler B., Cornélissen G., Huether G., Hardeland R., Józsa R., Zeman M., Stebelova K., Oláh A., Bubenik G., Pan W., Otsuka K., Schwartzkopff O., Bakken E.E., Halberg F. |
| 20472 |
THE ONCOLOGIST |
Combined therapy with weekly irinotecan, infusional 5-fluorouracil and the selective COX-2 inhibitor rofecoxib is a safe and effective second-line treatment in metastatic colorectal cancer. |
2005-10-01 |
10.1634/theoncologist.10-9-710 |
Gasparini G. |
| 20471 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Effect of aging on blood pressure in Leh, Ladakh, a high-altitude (3524 m) community, by comparison with a Japanese town |
2005-10-01 |
10.1016/s0753-3322(05)80011-3 |
Otsuka K., Norboo T., Otsuka Y., Higuchi H., Hayajiri M., Narushima C., Sato Y., Tsugoshi T., Murakami S., Wada T., Ishine M., Okumiya K., Matsubayashi K., Yano S., Choygal T., Angchuk D., Ichihara K., Cornélissen G., Halberg F. |
| 20470 |
THE ONCOLOGIST |
Preclinical perspectives on bisphosphonate renal safety. |
2005-10-01 |
10.1634/theoncologist.10-90001-3 |
Body J.-J. |
| 20469 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Prokaryotic and eukaryotic unicellular chronomics |
2005-10-01 |
10.1016/s0753-3322(05)80031-9 |
Halberg F., Cornélissen G., Faraone P., Poeggeler B., Hardeland R., Katinas G., Schwartzkopff O., Otsuka K., Bakken E.E. |
